Credit Suisse Downgrades Pharmacyclics To Neutral By: Benzinga via Benzinga February 27, 2015 at 08:33 AM EST Analysts at Credit Suisse downgraded Pharmacyclics Inc. (NASDAQ: PCYC) from Outperform to Neutral. The price target for Pharmacyclics ... Read More >>